Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) EPS (Weighted Average and Diluted) (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.21 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 50.0% year-over-year to -$0.21; the TTM value through Sep 2025 reached -$0.69, down 165.38%, while the annual FY2024 figure was -$0.25, 78.81% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.21 in Q3 2025 per GOSS's latest filing, down from -$0.17 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.22 in Q2 2024 and bottomed at -$0.76 in Q1 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.32, with a median of -$0.21 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 148.89% in 2024, then tumbled 177.27% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.57 in 2022, then soared by 73.68% to -$0.15 in 2023, then fell by 0.0% to -$0.15 in 2024, then plummeted by 40.0% to -$0.21 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.21 in Q3 2025, -$0.17 in Q2 2025, and -$0.16 in Q1 2025.